Stay updated on TEV-48574 Long-Term Efficacy in IBD Clinical Trial
Sign up to get notified when there's something new on the TEV-48574 Long-Term Efficacy in IBD Clinical Trial page.

Latest updates to the TEV-48574 Long-Term Efficacy in IBD Clinical Trial page
- Check4 days agoChange DetectedThe study’s location directory has been substantially updated: named hospitals and research centers across the United States and other countries are listed in place of many Teva investigational-site identifiers.SummaryDifference3%

- Check11 days agoChange DetectedThe record provides details for Teva’s Phase 2b long-term study of TEV-48574 in adults with moderate to severe ulcerative colitis or Crohn’s disease, including trial procedures, outcomes, eligibility, and locations. It also includes information about sharing participant-level data and the study’s record history.SummaryDifference85%

- Check18 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check32 days agoChange DetectedAn NIH website-transition notice appears above the study record’s 403 error page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe site revision in the footer changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error page, including the 403 header and basic site chrome, replacing the expected study details. This indicates an access restriction rather than an update to the study information.SummaryDifference17%

Stay in the know with updates to TEV-48574 Long-Term Efficacy in IBD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TEV-48574 Long-Term Efficacy in IBD Clinical Trial page.